Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00990288 · ClinicalTrials.gov registry record · Phase 4
The Use of FLOSEAL to Reduce Bleeding in Total Knee Replacement Surgery
A Phase 4 study, sponsored by Hospital for Special Surgery, New York.
- Completed
- Registry status
- Phase 4
- Development phase
- 196
- Enrollment target
NCT00990288: Completed Phase 4 study, sponsored by Hospital for Special Surgery, New York.
NCT00990288 is a Phase 4 study that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 196 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (62% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00990288, a Phase 4 study, has completed, sponsored by Hospital for Special Surgery, New York.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 196 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the agent, Floseal, can decrease the amount of blood patients lose after total knee replacement (TKR) surgery. If this product can be found to have an effect on bleeding, it may potentially reduce the problems associated with bleeding after knee replacement surgery such as pain, stiffness, and the need to have a blood transfusion. The subject's overall participation will be over a period of 6 weeks.
Interventions
- DRUG Hemostatic Matrix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 196 participants |
| Start Date | 2007-10 |
| Est. Completion | 2010-08 |
| Phase | Phase 4 |
What the finished NCT00990288 record still lists
NCT00990288 is an interventional study that assigns participants to a tested intervention. The registered 196 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (62% lower).
The record links to 0 conditions, and to 1 intervention - of which Hemostatic Matrix is the first listed.
NCT00990288 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00990288 about?
NCT00990288 is a clinical study titled "The Use of FLOSEAL to Reduce Bleeding in Total Knee Replacement Surgery". The purpose of this study is to determine if the agent, Floseal, can decrease the amount of blood patients lose after total knee replacement (TKR) surgery. If this product can be found to have an effect on bleeding, it may potentially reduce the problems associated with bleeding after knee replaceme...
What is the current status of trial NCT00990288?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 196 participants. The study started on 2007-10. Estimated completion is 2010-08.
What interventions are being tested in trial NCT00990288?
The interventions under investigation include: Hemostatic Matrix (DRUG).
Who is sponsoring clinical trial NCT00990288?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00990288's enrollment target sits among peer trials
196 449th of 2000 higher than 1,551 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02822768 · 196 participants · NA
Packing Versus no Packing for Cutaneous Abscess
- NCT04250259 · 196 participants · Phase 2
SAMe Trial for Patients With Alcoholic Cirrhosis
- NCT05142592 · 196 participants · Phase 1
Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors
- NCT05317832 · 196 participants · Phase 2
Using Smartphones to Improve Physical Activity Levels of Individuals With Spinal Cord Injury
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia